Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ralph Boccia, MD
Center for Cancer and Blood Disorders
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Compassionate Cancer Care Medical Group
Corona, California, United States
- Compassionate Care Medical Group
Fountain Valley, California, United States
- Ventura County Hematology Oncology
Oxnard, California, United States
- Compassionate Cancer Care Medical Group
Riverside, California, United States
- Cancer Center of Southern California
Santa Monica, California, United States
- Eastern Connecticut Hematology and Oncology
Norwich, Connecticut, United States
- South Florida Cancer Care
Margate, Florida, United States
- Florida Cancer Affiliates-Ocala
Ocala, Florida, United States
- Mid-Florida Hematology Oncology Center
Orange City, Florida, United States
- Comprehensive Hematology Oncology
St. Petersburg, Florida, United States
- Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
- Mary Bird Perkins
Baton Rouge, Louisiana, United States
- Maryland Oncology Hematology
Annapolis, Maryland, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- Maryland Oncology Hematology
Bethesda, Maryland, United States
- Maryland Oncology Hematology
Brandywine, Maryland, United States
- Maryland Oncology Hematology
Columbia, Maryland, United States
- Maryland Oncology Hematology
Lanham, Maryland, United States
- Maryland Oncology Hematology
Rockville, Maryland, United States
- Maryland Oncology Hematology
Silver Spring, Maryland, United States
- Health Partners Institute-Mmorc
Saint Louis Park, Minnesota, United States
- Oncology Hematology Associates
Springfield, Missouri, United States
- New Jersey Center for Cancer Research
Brick, New Jersey, United States
- Hunterdon Regional Cancer Center
Flemington, New Jersey, United States
- Minniti Center for Oncology and Hematology
Mickleton, New Jersey, United States
- Southeastern Medical Oncology Center
Jacksonville, North Carolina, United States
- Regional Medical Oncology Center
Wilson, North Carolina, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Zangmeister Cancer Center
Columbus, Ohio, United States
- Alliance Cancer Specialists
Bensalem, Pennsylvania, United States
- Consultants in Medical Oncology Hematology
Broomall, Pennsylvania, United States
- Pennsylvania Cancer Specialists and Research Institute
Gettysburg, Pennsylvania, United States
- Alliance Cancer Specialists
Horsham, Pennsylvania, United States
- Alliance Cancer Specialists
Langhorne, Pennsylvania, United States
- Alliance Cancer Specialists
Philadelphia, Pennsylvania, United States
- Alliance Cancer Specialists
Sellersville, Pennsylvania, United States
- Alliance Cancer Specialists
Wynnewood, Pennsylvania, United States
- Tidelands Health Oncology
Murrells Inlet, South Carolina, United States
- Carolina Blood and Cancer Care Associates
Rock Hill, South Carolina, United States
- Summit Cancer Centers
Spokane Valley, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jun 2022
- Primary completion
- 29 Apr 2023
- Completion
- 30 Jun 2023
- Last update posted
- 8 Sept 2023
- Registered enrollment
- 550
- Registry id
- NCT05438498
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.